All combined, our findings suggest that high levels of NfL and synaptic proteins are predictive of cognitive decline in early AD stages, with SNAP-25 as most promising biomarker, and further increase of especially NfL and SNAP-25 levels is associated with faster cognitive decline in the dementia stage of AD. The gene discussed is NEFL; the disease is Alzheimer disease.